The bill adds cancer prevention programs to the Assistance to Firefighters Grant (AFG) statute, explicitly permitting grant funds to be used for multi-cancer early detection testing and other preventative tests for firefighting personnel. It also directs FEMA and CDC to operate a voluntary, anonymized data-sharing program so test results can be analyzed for trends and causes of cancer among firefighters.
This change embeds screening and surveillance into a long-standing federal grant program used by local fire departments, signaling a federal push toward prevention and research. Departments, test vendors, FEMA, and CDC will face new operational choices about how to deploy tests, protect privacy, and use limited grant dollars for screening versus other firefighter needs.
At a Glance
What It Does
It amends the Federal Fire Prevention and Control Act to let Assistance to Firefighters grants cover cancer-prevention programs for firefighting personnel, including multi-cancer early detection or other preventative tests, and it establishes a joint FEMA–CDC voluntary program to collect anonymized test results for research.
Who It Affects
Local and volunteer fire departments that apply for AFG funds, FEMA as grant administrator, CDC as research partner, providers of multi-cancer early detection tests, and occupational-health researchers tracking firefighter cancer trends.
Why It Matters
The bill shifts part of the AFG program from equipment and training toward clinical prevention and surveillance, creating federal support and data infrastructure for firefighter cancer detection while raising choices around evidence, privacy, and resource allocation.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The core statutory change inserts a new eligible activity into the Assistance to Firefighters Grant program: establishing cancer prevention programs for firefighting personnel. That language specifically references multi-cancer early detection testing as an example, making such tests a permitted use of AFG grant dollars rather than leaving screening to other programs or local budgets.
Practically, departments could apply for AFG money to buy tests, set up screening protocols, pay for associated clinical services, or stand up related program infrastructure.
The bill limits how grant funds are spent at the transaction level by placing a per-test ceiling on obligations from the new grant category. It also creates a line-item authorization for grant money dedicated to these cancer prevention programs.
Those two mechanics — a per-test cap and a specific authorization — will together shape which tests departments buy, how many personnel can be screened, and how FEMA prioritizes awards during grant cycles.Separately, the bill instructs FEMA and the Centers for Disease Control and Prevention to jointly run a voluntary program through which firefighting personnel may share test results for research. The statute requires shared results to be de-identified and anonymized to prevent attribution.
This creates a federal pathway for assembling a large, occupation-specific dataset on cancer biomarkers and early-detection signals, but the statute stops short of mandating participation or specifying analytic protocols.Finally, the bill contains a small technical renumbering and conforming amendment to integrate the new subparagraph into the existing statutory structure. That prepares the Assistance to Firefighters Grant statute to accept the new category without disturbing other eligible-activity language, but it does not change existing eligibility rules, matching requirements, or administrative procedures that govern how departments apply for and administer AFG awards.
The Five Things You Need to Know
The bill adds a new eligible use to section 33(c)(3) of the Federal Fire Prevention and Control Act permitting AFG funds to establish cancer prevention programs for firefighting personnel and explicitly cites multi-cancer early detection testing as an example.
It caps grant obligations for any single multi-cancer early detection or preventative test at $1,750 paid from the new grant category.
The statute authorizes $700,000,000 specifically for grants made under the new cancer-prevention grant authority.
FEMA and CDC must jointly create a voluntary program to collect and analyze shared testing results from firefighting personnel; those results must be anonymized and de-identified to avoid attribution to individuals.
Congressional text renumbers existing subparagraphs to insert the new authority and includes a technical conforming amendment to preserve cross-references in section 33(i).
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Adds cancer prevention programs as an eligible grant activity
The bill inserts a new subparagraph (F) into the list of allowable Assistance to Firefighters Grant activities, authorizing grants to cover the establishment of cancer prevention programs for firefighting personnel and explicitly mentioning multi-cancer early detection testing. Practically, this creates statutory permission for departments to request AFG funds for clinical screening, program coordination, and associated services that previously were not spelled out in the AFG eligibility language.
Per-test spending limit from grant funds
The bill adds a new paragraph to section 33(i) that caps obligations and expenditures from the new cancer-prevention grant bucket at $1,750 per multi-cancer early detection or preventative test. That cap is an administrative constraint: FEMA cannot obligate AFG funds above this amount for a single test, which will affect procurement choices, negotiation with vendors, and how departments design screening programs to reach as many personnel as possible within grant awards.
Dedicated authorization for cancer-prevention grants
A new paragraph authorizes $700,000,000 for grants under the newly added cancer-prevention category. Authorization is not the same as appropriation: it signals congressional intent and sets an upper bound on what could be appropriated for these grants, but agencies can only spend what Congress actually appropriates and how it directs in appropriations language.
Voluntary FEMA–CDC data-sharing program for research
The bill creates a joint program run by FEMA and CDC in which firefighting personnel may voluntarily share results of multi-cancer early detection or preventative tests. The program requires that shared results be anonymized and de-identified to safeguard personally identifiable information and prevent attribution to individuals. The provision assigns responsibility for establishing the program but leaves implementation details — consent procedures, data standards, reporting timelines, and analytic methods — to the agencies.
Statutory renumbering and cross-reference fix
To accommodate the new subparagraph, the bill renumbers existing subparagraphs and updates a cross-reference in section 33(i)(1). This is mechanical but necessary: it avoids internal inconsistencies in the Assistance to Firefighters Grant statute and preserves the integrity of other grant-authority text.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Firefighting personnel (career and volunteer): They gain clearer, federal-supported access to organized screening programs and the potential for earlier detection through multi-cancer tests, which can improve individual health surveillance and follow-up.
- Local fire departments and EMS agencies: Departments can apply for AFG money to cover screening costs and program infrastructure, relieving local budgets and enabling institutions that lacked resources to initiate testing programs.
- Occupational-health researchers and public-health agencies: The FEMA–CDC voluntary dataset creates an occupation-focused pool of anonymized test results that can be analyzed for exposure patterns and early markers of cancer.
- Manufacturers and providers of multi-cancer early detection tests: Eligible purchases through AFG may increase demand for these products and services among fire departments seeking to establish prevention programs.
Who Bears the Cost
- FEMA and the Assistance to Firefighters Grant program: FEMA must incorporate the new grant category into its application, award, and monitoring processes and manage the $1,750 per-test limit administratively.
- Centers for Disease Control and Prevention: CDC will need to allocate staff, systems, and analytic resources to receive anonymized data, run trend analyses, and coordinate with FEMA under the joint program.
- Federal budget/appropriators: The $700 million authorization creates a potential fiscal exposure that appropriators must consider; actual outlays depend on future appropriations decisions.
- Local departments that exceed the per-test cap with existing clinical arrangements: Departments that prefer tests costing more than the statutory cap will either pay the excess locally or choose lower-cost alternatives, shifting financial burdens to local budgets.
Key Issues
The Core Tension
The central dilemma is whether limited federal grant dollars should underwrite clinical screening and surveillance for firefighters — potentially catching cancers earlier — or be reserved for primary prevention and operational needs that reduce exposure in the first place; the statute leans toward screening and research but leaves open whether this produces better outcomes per dollar than investments in exposure control, and it creates privacy and evidentiary trade-offs given ambiguous definitions and technical standards.
The bill mixes programmatic encouragement with modest administrative guardrails, but it leaves several practical questions unresolved. It does not define “multi-cancer early detection” or set clinical standards, leaving departments and FEMA to judge which tests qualify.
The per-test ceiling creates a blunt spending constraint that may not reflect market prices or the evidence base for particular tests; departments could be forced into lower-cost options with different sensitivity and specificity profiles. The $700 million is an authorization, not an appropriation, so implementation depends on future budget action.
On data and privacy, the bill requires anonymization but does not specify technical standards or consent mechanisms. De-identification is nontrivial with genomic or biomarker data: re-identification risks, linkage threats, and the need for clear participant consent and data-use agreements will fall to FEMA and CDC to resolve.
Finally, the statute commits federal grant dollars to clinical screening rather than to traditional exposure-prevention investments (PPE, decontamination, contamination-reducing protocols), raising a latent resource-allocation debate between prevention at the source and secondary prevention through screening.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.